The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population

The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population

Background. The BRAF V600E mutation is an important genetic event in papillary thyroid cancer (PTC). This study aimed to provide additional information regarding the association of the BRAF V600E mutation with PTC prognosis. Methods. A retrospective single-center study based on a Chinese population...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ziheng Ye, Xiaotian Xia, Peipei Xu, Wenfei Liu, Shoufei Wang, Youben Fan, Minggao Guo
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2022/6562149
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In-depth characterization of miRNome in papillary thyroid cancer with BRAF V600E mutation
by: Azliana Mohamad Yusof, et al.
Published: (2020-03-01)

Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer
by: Marco Capezzone, et al.
Published: (2024-01-01)

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients
by: Li-Bo Yang, et al.
Published: (2015-01-01)

A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
by: Richard J. Robbins, et al.
Published: (2020-01-01)

BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01)

How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications
by: Catherine E. Bond, et al.
Published: (2018-01-01)

Detection of BRAF V600E in Fine-Needle Aspiration Samples of Thyroid Nodules by Droplet Digital PCR
by: Sang-Yu Lu, et al.
Published: (2022-01-01)

BRAF V600E-Negative Hairy Cell Leukaemia
by: Stephen E. Langabeer, et al.
Published: (2013-01-01)

Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation
by: Rūta Čepulytė, et al.
Published: (2020-01-01)

BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
by: Yasar Subutay Peker, et al.
Published: (2018-01-01)

Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE‐4.5 study
by: Susanne Klein‐Scory, et al.
Published: (2025-02-01)

Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
by: K. Sahadudheen, et al.
Published: (2016-01-01)

Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation
by: Mario Rotondi, et al.
Published: (2016-01-01)

BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01)

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
by: Arianna Marinello, MD, et al.
Published: (2025-03-01)

Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors
by: Michael Hoffmeister, et al.
Published: (2025-02-01)

Case report: a rare case of diffusely metastatic BRAF V600E-mutated colorectal cancer with concomitant infiltration of the skin and parotid gland
by: Aristeidis E. Boukouris, et al.
Published: (2025-01-01)

A Micro-RNA Connection in BRafV600E-Mediated Premature Senescence of Human Melanocytes
by: Gang Ren, et al.
Published: (2012-01-01)

RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
by: Bello Abdullahi Umar, et al.
Published: (2019-12-01)

Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer
by: Fadi Nabhan, et al.
Published: (2021-01-01)

Simultaneous Pheochromocytoma, Paraganglioma, and Papillary Thyroid Carcinoma without Known Mutation
by: Lorena Rasquin, et al.
Published: (2018-01-01)

Loss of Lkb1 cooperates with BrafV600E and ultraviolet radiation, increasing melanoma multiplicity and neural‐like dedifferentiation
by: Kimberley McGrail, et al.
Published: (2025-02-01)

BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression
by: Chuang Li, et al.
Published: (2025-01-01)

A Papillary Thyroid Microcarcinoma Revealed by a Single Bone Lesion with No Poor Prognostic Factors
by: Yann Godbert, et al.
Published: (2013-01-01)

Precise Detection of Gene Mutations in Fine-Needle Aspiration Specimens of the Papillary Thyroid Microcarcinoma Using Next-Generation Sequencing
by: Feng-xia Yu, et al.
Published: (2019-01-01)

Association Analysis of MET Gene Polymorphism with Papillary Thyroid Carcinoma in a Chinese Population
by: Lifeng Ning, et al.
Published: (2015-01-01)

Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma
by: Jeremy Chuang, et al.
Published: (2019-01-01)

Frecuencia de la inmunosupresión de BRAF V600E en ameloblastomas: Un análisis multi-insituticional de 86 casos en América Latina
by: Lauren Frenzel Schuch, et al.
Published: (2024-12-01)

Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma
by: Elisabetta Cavedon, et al.
Published: (2017-01-01)

Uncommon BRAF Mutations Associated with Durable Response to Immunotherapy in Patients with Metastatic Melanoma
by: Brenen P. Swofford, et al.
Published: (2017-01-01)

Clinical Treatment Status of Papillary Thyroid Microcarcinoma
by: Liu Tong, Meng Kexin, Zhu Ying, Fan Fengjing, Wang Bei
Published: (2025-03-01)

Anaplastic Transformation of Papillary Thyroid Cancer in the Retroperitoneum
by: James P. Solomon, et al.
Published: (2015-01-01)

Morphological and immunohistochemical analysis in encapsulated follicular variant papillary thyroid carcinoma, invasive follicular variant papillary thyroid carcinoma and a new entity: non-invasive follicular thyroid neoplasm with papillary nuclear feature
by: Zeliha Çelik, et al.
Published: (2024-12-01)

Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients
by: Dongxue Zhang, et al.
Published: (2017-01-01)

KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
by: Daniele Calistri, et al.
Published: (2006-01-01)

A case report of infantile fibrosarcoma with BRAF gene mutation with incomplete intestinal obstruction
by: Fan Zhu, et al.
Published: (2025-01-01)

Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study
by: Liu Yihao, et al.
Published: (2022-01-01)

A Rare Case of Multifocal Papillary Thyroid Cancer in Bilateral Thyroid Cysts
by: Anupama Roy Chowdhury, et al.
Published: (2018-01-01)

Metastatic Papillary Thyroid Carcinoma with Multifocal Synchronous Transformation to Anaplastic Thyroid Carcinoma
by: Mark Benedict, et al.
Published: (2016-01-01)

Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas
by: Firas Warda, et al.
Published: (2022-01-01)